-
Risk of Parkinson's disease dementia related to level I MDS PD-MCI
on behalf of the MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”, 1 Mar 2019, In: Movement disorders. 34, 3, p. 430-435 6 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Randomized Delayed-Start Trial of Levodopa in Parkinson's Disease
LEAP Study Group, 24 Jan 2019, In: New England journal of medicine. 380, 4, p. 315-324 10 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Levodopa en ziekteprogressie bij de ziekte van Parkinson
Suwijn, S. R., Verschuur, C. V. M., Boel, J. A., Post, B., Bloem, B. R., van Hilten, B. J., van Laar, T., Tissingh, G., Munts, A. G. & de Bie, R. M. A., 2019, In: Tijdschrift voor neurologie en neurochirurgie. 120, 4, p. 133-140Research output: Contribution to journal › Article* › Professional
- All publications
